GlassScriptPhysician profile
Varun Kumar Pala
NPI 1154877405
$1,747.15
in general payments reported to CMS, 2019-2025
20 companies · $38.99 in 2025
The $38.99 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $123 · 2021: $244 · 2022: $391 · 2023: $319 · 2024: $179 · 2025: $38.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $340.07 | 2022-2023 | Uplizna |
| Amgen INC. | $217.57 | 2024-2025 | Uplizna |
| Sk Life Science, INC. | $127.98 | 2021-2023 | |
| Grt US Holding, INC. | $123.33 | 2022 | |
| Allergan, INC. | $123.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $122.04 | 2019 | |
| Eisai INC. | $111.76 | 2019 | |
| Sunovion Pharmaceuticals INC. | $109.79 | 2019 | |
| Acadia Pharmaceuticals INC | $106.53 | 2021 | |
| Alexion Pharmaceuticals, INC. | $84.75 | 2021-2023 | Ultomiris |
| Lilly USA, LLC | $84.72 | 2019 | |
| Lundbeck LLC | $47.82 | 2022 | |
| Aquestive Therapeutics, INC. | $23.86 | 2019 | |
| Ucb, INC. | $20.90 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $20.72 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $18.01 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $17.21 | 2022 | |
| Genentech USA, INC. | $17.04 | 2022 | |
| Biogen, INC. | $16.43 | 2021 | |
| Neurelis, INC. | $13.38 | 2023 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Kumar Pala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.